增强型体外反搏治疗冠心病不稳定型心绞痛疗效观察  

Clinical effect of enhanced external counterpulsation(EECP) on the treatment of unstable angina pectoris(UAP)

作　　者：陈小卫[1] 黄志文[1] 田丽红[1] 

机构地区：[1]广东医学院附属医院心内科,524000

出　　处：《中国实用医药》2011年第5期17-18,共2页China Practical Medicine

摘　　要：目的观察增强型体外反搏治疗冠心病不稳定型心绞痛的临床疗效。方法将82例冠心病不稳定型心绞痛患者随机分为对照组和治疗组,对照组常规给予硝酸盐制剂、β受体阻滞剂、钙拮抗剂、双联抗血小板(阿司匹林和硫酸氯吡格雷)、他汀类调脂药物及低分子肝素等;治疗组在常规药物治疗基础上加用增强型体外反搏治疗,观察两组临床疗效及心电图变化。结果治疗后总有效率治疗组85.7%,对照组65.0%;心电图改善率分别为76.2%和52.5%,治疗组无严重不良反应发生。结论增强型体外反搏治疗冠心病不稳定型心绞痛安全有效。Objective To observe the effect of EECP on the treatment of UAP.Methods 82 cases with UAP were randomly divided into control group.Therapy group and the control group were treated with routine drugs such as Nitrites,β-blocker,calcium channel blocker,combined antiplatelet,statin and low molecular weight heparin,but the therapy group were treated with EECP in addition to the routine drugs,and the clinical effect and change of the electrocardiogram（ECG） were evaluated.Results The total effective rate and change rate of ECG were 85.7% and 76.2% in therapy group while 65.0% and 52.5% respectively in control group,the differences were of statistical sense（P〈0.05）.No serve adverse reaction happened in the therapy group.Conclusion EECP is effective and safe for the treatment of UAP.

关 键 词：增强型体外反搏 冠心病 不稳定型心绞痛 

分 类 号：R541.4[医药卫生—心血管疾病]